steroid cards

September 23rd 2021

In August 2020, in response to four deaths and more than 300 reported incidents with steroid replacement therapy involving patients with adrenal insufficiency, a National Patient Safety Alert was published by NHS England and NHS Improvement announcing the introduction of a new patient-held steroid EMERGENCY card. All patients with primary adrenal insufficiency are steroid dependent…

Read More

January 18th 2021

We have had some interesting queries over the past few months which have required some time to answer in full. We also had some feedback from previous queries which we respond to below. All our visiting pharmacists are there to respond to your queries and if they can’t answer the question on the spot, we…

Read More

January 18th 2021

The MHRA has repeated its concerns about overuse of opioids based on a set of recommendations from its Opioid Expert Working Group of the Commission on Human Medicines. The first step taken was to put safety warnings on packs of medicines containing opioids. They now want to ensure people are supplied with consistent information on…

Read More

January 18th 2021

It is generally accepted that the management of symptoms in palliative care must involve appropriate polypharmacy. We are comfortable with using more than one medicine to help with one symptom provided the mechanisms of action are different and complementary – for example morphine plus gabapentin for pain with neuropathic characteristics. At the same time, we…

Read More

September 1st 2020

The two opioids available for delivery via a transdermal patch in the UK are fentanyl and buprenorphine. Fentanyl products are licensed for severe and chronic pain that requires long-term opioids or that does not respond to non-opioids. Buprenorphine is available in two sets of products – the stronger patches have a similar license to fentanyl while the lower strengths are indicated for non-malignant pain when an opioid is necessary (they are used for cancer pain in some cases, where patients only require low opioid doses)…

Read More

September 1st 2020

One of the audits collected on our Ashtons Live View system is the number of prescription items for each patient. This information enables us to provide you with comparative data and percentages for our clinical interventions. It is not unusual to count more than twenty items for one patient on a hospice drug chart, although many of these items will be on the PRN pages. We pay great attention to detail with the patient’s response to their medicines, but what are the prompts for reducing the number of items?

Read More